ASIA PACIFIC BREAST IMPLANTS MARKET ANALYSIS

Market News

Asia Pacific Breast Implants Market : Key Developments

In October 2022, Second Affiliated Hospital, School of Medicine, Zhejiang University, a hospital based in China, in collaboration with Affiliated Hangzhou First People's Hospital, Zhejiang University, hospital based in China initiated the clinical trial study titled 'Axillary Versus Primary Breast Approach for Second-stage Operation in Expander-Implant Breast Reconstruction'. The study is estimated to get completed by the December 2024.

In August 2022, BellaSeno GmbH, a medical technology manufacturing company announced that its proprietary 3D printed breast implants has entered human trials. BellaSeno's 3D printed breast scaffolds are fully-resorbable, in that they are designed to be implanted during breast regeneration, augmentation or revision surgeries, before being slowly absorbed by the body.

In April 2022, GC Aesthetics (GCA), medical technology company, announced the it has gained the approval from the U.S. Food and Drug Administration for its new breast implant named LUNA xt micro-textured anatomical breast implant.

In May 2022, Prayasta 3D Inventions Pvt Ltd, Pune-based startup,  won the national technology award for 2022 presented by the Department of Science and Technology (DST). It is an avid supplier of rupture-free 3D breast implants and prosthetics, by using its indigenously developed iEAM technology (elastomer additive manufacturing).